Clinical implications of ketorolac for postoperative analgesia

Journal of Perianesthesia Nursing

Volumn 12, Issue 6, 1997, Pages 426-433

  Fiedler, Michael A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DRUG DERIVATIVE; KETOROLAC; TOLMETIN;

CONVALESCENCE; HUMAN; LENGTH OF STAY; POSTOPERATIVE PAIN; REVIEW;

ANALGESICS, NON-NARCOTIC; CONVALESCENCE; HUMANS; KETOROLAC; LENGTH OF STAY; PAIN, POSTOPERATIVE; TOLMETIN;

EID: 0031302179     PISSN: 10899472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-9472(97)90006-X     Document Type: Article

References (54)

1. Murray AW, Brockway MS, Kenny GNC: Comparison of the cardiorespiratory effects of ketorolac and alfentanil during propofol anaesthesia. Br J Anaesth 63:601-603, 1989
2. Brandon LJC, Mattie H, Spierdijk J, et al: The effects on ventilation of ketorolac in comparison with morphine. Eur J Clin Pharmacol 35:491-494, 1988
3. Rooks II WH, Tomolonis AJ, Maloney PJ, et al: The analgesic and anti-inflammatory profile of (±)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid (RS 37619). Agents Actions 12:684-690, 1982
4. Rooks IIWH, Maloney PJ, Shott LD, et al: The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drugs Exp Clin Res 11:479-492, 1985
5. Oosterlinck W, Philp NH, Charig C, et al: A doubleblind single dose comparison of intramuscular ketorolac tromethamine and pethidine in the treatment of renal colic. J Clin Pharmacol 30:336-341, 1990
6. Folsland B, Skulberg A, Halvorsen P, et al: Placebocontrolled comparison of single intramuscular doses of ketorolac tromethamine and pethidine for postoperative analgesia. J Int Med Res 18:305-314, 1990
7. O'Hara DA, Fragen RJ, Kinser M, et al: Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain. Clin Pharmacol Ther 41:556-561, 1987
8. Yee JP, Koshiver JE, Allbon C, et al: Comparison of intramuscular ketorolac tromethamine and morphine sulfate for analgesia of pain after major surgery. Pharmacotherapy 6:253-261, 1986
9. Brown CR, Mazzulla JP, Mod MS, et al: Comparison of repeat doses of intramuscular ketorolac tromethamine and morphine sulfate for analgesia after major surgery. Pharmacotherapy 10:45S-50S, 1990
10. Power I, Noble DW, Douglas E, et al: Comparison of IM ketorolac tromethamine and morphine sulphate for pain relief after cholecystectomy. Br J Anaesth 65:448-455, 1990
11. Powell H, Smallman JM, Morgan M: Comparison of intramuscular ketorolac and morphine in pain control after laparotomy. Anaesthesia 45:538-542, 1990
12. Kinsella J, Moffat AC, Patrick JA, et al: Ketorolac tromethamol for postoperative analgesia after orthopaedic surgery. Br J Anaesth 69:19-22, 1992
13. Smith I, Shively RA, White PF: Effects of ketorolac and bupivacaine on recovery after outpatient arthroscopy. Anesth Analg 75:208-212, 1992
14. Ready LB, Brown CR, Stahlgren LH, et al: Evaluation of intravenous ketorolac administered by bolus or infusion for treatment of postoperative pain. Anesthesiology 80:1277-1286, 1994
15. Sevarino FB, Sinatra RS, Paige D, et al: The efficacy of intramuscular ketorolac in combination with intravenous PCA morphine for postoperative pain relief. J Clin Anesth 4:285-288, 1992
16. Resman-Targoff BH: A parenteral nonsteroidal antiinflammatory drug. DICP 24:1098-1104, 1990
17. Mroszczak EJ, Jung D, Yee J, et al: Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy 10:33S-39S, 1990
18. Brocks DR, Jamali F: Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet 23:415-427, 1992
19. Mroszczak EJ, Lee FW, Combs S, et al: Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans. Drug Metab Dispos 15:618-626, 1987
20. Jung D, Mroszczak E, Bynum L: Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration. Eur J Clin Pharmacol 35:423-425, 1988
21. Jallad NS, Garg DC, Martinez JJ, et al: Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly. J Clin Pharmacol 30:76-81, 1990
22. Olkkola KT, Maunuksela EL: The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children. Br J Clin Pharmacol 31:182-184, 1991
23. Martinez JJ, Garg DC, Pages LJ, et al: Single dose pharmacokinetics of ketorolac in healthy young and renal impaired subjects. J Clin Pharmacol 27:722, 1987
24. Roe RL, Bruno JJ, Ellis DJ: Effects of a new nonsteroidal anti-inflammatory agent on platelet function in male and female subjects. Clin Pharmacol Ther 29:277, 1981
25. Greer IA: Effects of ketorolac tromethamine on hemostasis. Pharmacotherapy 10:71S-76S, 1990
26. Toon S, Holt BL, Mullins FG, et al: Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin. Br J Clin Pharmacol 30:743-750, 1990
27. Conrad KA, Fagan TC, Mackie MJ, et al: Effects of ketorolac tromethamine on hemostasis in volunteers. Clin Pharmacol Ther 43:542-546, 1988
28. Spowart K, Grecr IA, McLaren M, et al: Haemostatic effects of ketorolac with and without concomitant heparin in normal volunteers. Thromb Haemost 60:382-388, 1988
29. Thwaites BK, Nigus DB, Bouska GW, et al: Intravenous ketorolac tromethamine does not worsen platelet function during knee arthroscopy under general anesthesia. Anesth Analg 81:119-124, 1995
30. Koh SC, Pua HL, Tay DH, et al: The effects of gynaecological surgery on coagulation activation, flbrinolysis and fibrinolytic inhibitor in patients with and without ketorolac infusion. Thromb Res 79:501-514, 1995
31. Strom BL, Berlin JA, Kinman JL, et al: Parenteral ketorolac and risk of gastrointestinal and operative site bleeding: A postmarketing surveillance study. JAMA 275:376-382, 1996
32. Weale AE, Warwick DJ, Durant N, et al: Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement? Ann R Coll Surg Engl 77:35-37, 1995
33. Traversa G, Walker AM, Ippolito FM, et al: Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology 6:49-54, 1995
34. Lanza FL, Karlin DA, Yee JF: A double-blind placebo controlled endoscopie study comparing the mucosal injury seen with an orally and parenterally administered new nonsteroidal analgesic ketorolac tromethamine at therapeutic and supratherapeutic doses. Am J Gastroenterol 82:939A, 1987
35. Estes LL, Fuhs DW, Heaton AH, et al: Gastric ulcer perforation associated with the use of injectable ketorolac. Ann Pharmacother 27:42-43, 1993
36. Maliekal J, Elboim CM: Gastrointestinal complications associated with intramuscular ketorolac tromethamine therapy in the elderly. Ann Pharmacother 29:698-701, 1995
37. Yee MK, Evans WD, Facey PE, et al: Gastric emptying and small bowel transit in male volunteers after IM ketorolac and morphine. Br J Anaesth 67:426-431, 1991
38. Kelley MC, Hocking MP, Marchand SD, et al: Ketorolac prevents postoperative small intestinal ileus in rats. Am J Surg 165:107-112, 1993
39. Quan DJ, Kayser SR: Ketorolac induced acute renal failure following a single dose. J Toxicol Clin Toxicol 32:305-309, 1994
40. Patel NY, Landercasper J: Ketorolac-induced postoperative acute renal failure: a case report. Wis Med J 94:445-447, 1995
41. Perazella MA, Buller GK: NSAID nephrotoxicity revisited: Acute renal failure due to parenteral ketorolac. South Med J 86:1424-1424, 1993
42. Haragsim L, Dalal R, Bagga H, et al: Ketorolac-induced acute renal failure and hyperkalerria: Report of three cases. Am J Kidney Dis 24:578-580, 1994
43. Pearch CJ, Gonzalez FM, Wallin JD: Renal failure and hyperkalemia associated with ketorolac tromethamine. Arch Intern Med 153:1000-1002, 1993
44. Rassmussen SN: Effects of osmotic diuresis and water diuresis on intrarenal red cell and plasma volumes in the rat. Pflügers Arch 1:1-11, 1974
45. Corwin HL, Bonventre JV: Renal insufficiency associated with nonsteroidal anti-inflammatory agents. Am J Kidney Dis 4:147-152, 1984
46. Specter SL, Wangaard BS, Farr RS: Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J Allergy Clin Immunol 64:500-506, 1979
47. Chen AH, Bennett CR: Ketorolac-induced bronchospasm in an aspirin-intolerant patient. Anesth Prog 41:102-107, 1994
48. Haddow GR, Riley E, Isaacs R, et al: Ketorolac, nasal polyposis, and bronchial asthma: A cause for concern. Anesth Analg 76:420-422, 1993
49. Zikowski D, Hord AH, Haddox JD, et al: Ketorolacinduced bronchospasm. Anesth Analg 76:417-419, 1993
50. Vicks SD, Dean RJ, Tenholder MF: Ketorolac induced respiratory failure in an aspirin sensitive asthmatic. Immunol Allergy Pract 13:23-25, 1991
51. Goetz CM, Sterchele JA, Harchelroad FP: Anaphylactoid reaction following ketorolac tromethamine administration. Ann Pharmacother 26:1237-1238, 1992
52. Floy BJ, Royko CG, Fieitman JS: Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets. Am J Hosp Pharm 47:1097-1100, 1990
53. Cade L, Kakulas P: Ketorolac or pethidine for analgesia after elective laparoscopic sterilization. Anaesth Intens Care 23:158-161, 1995
54. See WA, Fuller JR, Toner ML: An outcome study of patient-controlled morphine analgesia, with or without ketorolac, following radical retropubic prostatectomy. J Urol 154:1429-1432, 1995